DK575687A - Bicycliske forbindelser samt deres fremstilling og anvendelse - Google Patents

Bicycliske forbindelser samt deres fremstilling og anvendelse

Info

Publication number
DK575687A
DK575687A DK575687A DK575687A DK575687A DK 575687 A DK575687 A DK 575687A DK 575687 A DK575687 A DK 575687A DK 575687 A DK575687 A DK 575687A DK 575687 A DK575687 A DK 575687A
Authority
DK
Denmark
Prior art keywords
bicyclic
relations
preparation
bicyclic relations
Prior art date
Application number
DK575687A
Other languages
English (en)
Other versions
DK575687D0 (da
Inventor
Alban Imre Albert
Friedrich W Zilliken
Original Assignee
Zyma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zyma Sa filed Critical Zyma Sa
Publication of DK575687D0 publication Critical patent/DK575687D0/da
Publication of DK575687A publication Critical patent/DK575687A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/64—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with oxygen atoms directly attached in position 8
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
DK575687A 1986-11-04 1987-11-03 Bicycliske forbindelser samt deres fremstilling og anvendelse DK575687A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868626344A GB8626344D0 (en) 1986-11-04 1986-11-04 Bicyclic compounds

Publications (2)

Publication Number Publication Date
DK575687D0 DK575687D0 (da) 1987-11-03
DK575687A true DK575687A (da) 1988-05-05

Family

ID=10606782

Family Applications (1)

Application Number Title Priority Date Filing Date
DK575687A DK575687A (da) 1986-11-04 1987-11-03 Bicycliske forbindelser samt deres fremstilling og anvendelse

Country Status (15)

Country Link
US (1) US4814346A (da)
EP (1) EP0267155A3 (da)
JP (1) JPS63130589A (da)
KR (1) KR880006224A (da)
AU (1) AU606087B2 (da)
DD (1) DD275048A5 (da)
DK (1) DK575687A (da)
FI (1) FI874804A7 (da)
GB (1) GB8626344D0 (da)
HU (1) HUT48611A (da)
IL (1) IL84315A0 (da)
NO (1) NO874489L (da)
NZ (1) NZ222411A (da)
PT (1) PT86055B (da)
ZA (1) ZA878245B (da)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE40792E1 (en) * 1992-05-19 2009-06-23 Novogen Research Pty Ltd Health supplements containing phyto-oestrogens, analogues or metabolites thereof
ATE199716T1 (de) * 1993-12-08 2001-03-15 Alcon Lab Inc Verbindungen die sowohl starke calcium- antagonistische und antioxydatieve aktivitaet haben und deren verwendung als zellschuetzende mittel.
US5691360A (en) * 1993-12-08 1997-11-25 Alcon Laboratories, Inc. Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents
US5424321A (en) * 1993-12-08 1995-06-13 Alcon Laboratories, Inc. Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents
FR2731706B1 (fr) * 1995-03-14 1997-04-11 Cird Galderma Composes heterocycliques aromatiques, compositions pharmaceutiques et cosmetiques les contenant et utilisations
FR2736829B1 (fr) * 1995-07-20 1997-09-12 Oreal Composition pour lutter contre les taches et/ou le vieillissement de la peau, ses utilisations
GB9519033D0 (en) * 1995-09-18 1995-11-15 Smithkline Beecham Plc Treatment
DE19610932A1 (de) * 1996-03-20 1997-09-25 Bayer Ag 2-Aryl-substituierte Pyridine
HRP970330B1 (en) * 1996-07-08 2004-06-30 Bayer Ag Cycloalkano pyridines
DE19627430A1 (de) * 1996-07-08 1998-01-15 Bayer Ag Bicyclisch kondensierte Pyridine
US6207671B1 (en) * 1996-07-08 2001-03-27 Bayer Aktiengesellschaft Cycloalkano-pyridines
DE19627431A1 (de) * 1996-07-08 1998-01-15 Bayer Ag Heterocyclisch kondensierte Pyridine
AUPO203996A0 (en) * 1996-08-30 1996-09-26 Novogen Research Pty Ltd Therapeutic uses
US6034256A (en) * 1997-04-21 2000-03-07 G.D. Searle & Co. Substituted benzopyran derivatives for the treatment of inflammation
US6077850A (en) 1997-04-21 2000-06-20 G.D. Searle & Co. Substituted benzopyran analogs for the treatment of inflammation
US6146668A (en) 1997-04-28 2000-11-14 Novogen, Inc. Preparation of isoflavones from legumes
US6340703B1 (en) * 1997-05-01 2002-01-22 Novogen, Inc. Treatment or prevention of osteoporosis
AUPP112497A0 (en) * 1997-12-24 1998-01-22 Novogen Research Pty Ltd Compositions and method for protecting skin from UV induced immunosupression and skin damage
AUPP260798A0 (en) * 1998-03-26 1998-04-23 Novogen Research Pty Ltd Treatment of medical related conditions with isoflavone containing extracts of clover
AUPP868599A0 (en) * 1999-02-15 1999-03-11 Novogen Research Pty Ltd Production of isoflavone derivatives
AUPQ008299A0 (en) * 1999-04-30 1999-05-27 G.J. Consultants Pty Ltd Isoflavone metabolites
AUPQ266199A0 (en) * 1999-09-06 1999-09-30 Novogen Research Pty Ltd Compositions and therapeutic methods involving isoflavones and analogues thereof
US20090233999A1 (en) * 1999-09-06 2009-09-17 Novogen Research Pty Ltd Compositions and therapeutic methods involving isoflavones and analogues thereof
AUPQ520300A0 (en) * 2000-01-21 2000-02-17 Novogen Research Pty Ltd Food product and process
AUPR363301A0 (en) * 2001-03-08 2001-04-05 Novogen Research Pty Ltd Dimeric isoflavones
US20050119301A1 (en) * 2001-03-16 2005-06-02 Alan Husband Treatment of restenosis
AUPR846401A0 (en) * 2001-10-25 2001-11-15 Novogen Research Pty Ltd 6-Hydroxy isoflavones, derivatives and medicaments involving same
BR0313182A (pt) * 2002-07-24 2007-07-24 Childrens Hosp Medical Center composições e produtos contendo equol enantiomérico
WO2004039327A2 (en) 2002-10-29 2004-05-13 Colorado State University Research Foundation Use of equol for treating androgen mediated diseases
US8668914B2 (en) * 2002-07-24 2014-03-11 Brigham Young University Use of equol for treating skin diseases
WO2004014886A1 (en) * 2002-08-07 2004-02-19 University Of Mississippi Antigiardial agents and use thereof
AU2003265737B2 (en) * 2002-10-02 2008-10-16 Novogen Research Pty Ltd Combination chemotherapy compositions and methods
AU2002951833A0 (en) * 2002-10-02 2002-10-24 Novogen Research Pty Ltd Compositions and therapeutic methods invloving platinum complexes
US8580846B2 (en) 2002-10-29 2013-11-12 Brigham Young University Use of equol for ameliorating or preventing neuropsychiatric and neurodegenerative diseases or disorders
WO2005107770A1 (en) * 2004-04-28 2005-11-17 Brigham Young University Use of equol for treating skin diseases
ITTO20030140U1 (it) * 2003-09-16 2005-03-17 Interfila Srl Matita cosmetica
US20050065099A1 (en) 2003-09-19 2005-03-24 Gail Walkinshaw Treatment of mitochondrial diseases
US8080675B2 (en) 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
EP2407462B1 (en) 2004-09-21 2014-07-30 Marshall Edwards, Inc. Substituted chroman derivatives, medicaments and use in therapy
MX2007007103A (es) * 2004-12-13 2008-03-10 Lilly Co Eli Derivados espiro como inhibidores de lipoxigenasa.
AU2005328328A1 (en) 2005-02-25 2006-09-08 Galileo Pharmaceuticals, Inc. Spiro-heterocyclic chromans, thiochromans and dihydroquinolines
PT2471530T (pt) * 2005-06-01 2017-04-19 Edison Pharmaceuticals Inc Produtos terapêuticos com atividade redox para o tratamento de doenças mitocondriais e de outras condições e modulação de biomarcadores energéticos
US7528267B2 (en) 2005-08-01 2009-05-05 Girindus America, Inc. Method for enantioselective hydrogenation of chromenes
JP2009508867A (ja) * 2005-09-15 2009-03-05 エジソン ファーマシューティカルズ， インコーポレイテッド ミトコンドリア病および関連した様態の治療ならびにエネルギーバイオマーカーの調節のための酸化還元活性治療剤のテイル改変体
EP1986636B1 (en) 2006-02-22 2013-04-24 Edison Pharmaceuticals, Inc. Phenol and 1,4-benzoquinone derivatives for use in the treatment of mitochondrial diseases
US20070203227A1 (en) * 2006-02-24 2007-08-30 Herman Adlercreutz Isoflavan and isoflavene compounds and their use as angiogenesis inhibitors
JP2009542626A (ja) * 2006-06-27 2009-12-03 ジャワハーラル ネール センター フォー アドヴァンスド サイエンティフィック リサーチ メチルトランスフェラーゼ（ｈｍｔａｓｅ）の部位特異的阻害剤及びその製剤方法
CN101188435B (zh) * 2007-01-08 2011-03-16 中兴通讯股份有限公司 一种比特交织装置与方法
MX2010008111A (es) * 2008-01-24 2010-11-30 Endowment For Res In Human Biology Inc Inhibidores de aldh-2 en el tratamiento de adicciones.
EP2133080A1 (de) 2008-06-13 2009-12-16 Haelan Schweiz GmbH Zusammensetzungen enthaltend Equol
EP2324003A4 (en) * 2008-07-30 2011-11-16 Novogen Res Pty Ltd 6-SUBSTITUTED ISOFLAVONOIDE COMPOUNDS AND THEIR USE
US8314153B2 (en) 2008-09-10 2012-11-20 Edison Pharmaceuticals, Inc. Treatment of pervasive developmental disorders with redox-active therapeutics
WO2011100433A1 (en) 2010-02-12 2011-08-18 N30 Pharmaceuticals, Llc Novel s-nitrosoglutathione reductase inhibitors
JP5639665B2 (ja) 2010-02-12 2014-12-10 エヌサーティー・ファーマシューティカルズ・インコーポレーテッド Ｓ−ニトロソグルタチオンレダクターゼのクロモン阻害剤
EP2635121B1 (en) 2010-11-01 2020-01-08 MEI Pharma, Inc. Isoflavonoid compounds and methods for the treatment of cancer
HUE054998T2 (hu) 2015-02-02 2021-10-28 Mei Pharma Inc Kombinációs terápiák emlõrák kezelésében való alkalmazásra
CN104672192B (zh) * 2015-03-10 2017-07-28 中国药科大学 异黄酮酰胺类衍生物、其制备方法和医药用途
WO2017106803A1 (en) 2015-12-17 2017-06-22 Bioelectron Technology Corporation Flouroalkyl, flouroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3813415A (en) * 1972-07-28 1974-05-28 Grodziskie Zaklady Farma Polfa Process for the preparation of 3-(beta dialkylamino-ethyl)-4-alkyl-7-carboethoxymethoxycoumarins
US4157985A (en) * 1976-02-23 1979-06-12 Atlantic Richfield Company Chemical conversion method
US4264509A (en) * 1977-06-08 1981-04-28 Z-L Limited Partnership Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same
US4218489A (en) * 1977-06-08 1980-08-19 Z-L Limited Partnership Antioxidants, antioxidant compositions and methods of preparing and using same
US4232122A (en) * 1979-01-17 1980-11-04 Z-L Limited Partnership Antioxidants, antioxidant compositions and methods of preparing and using same
US4368264A (en) * 1979-03-19 1983-01-11 Z-L Limited Partnership Fermentation methods of preparing ergostadientriols
US4234577A (en) * 1979-03-19 1980-11-18 Z-L Limited Partnership Ergostadientriols, compositions containing same, and methods of preparing and using same

Also Published As

Publication number Publication date
EP0267155A3 (en) 1988-07-20
EP0267155A2 (en) 1988-05-11
DK575687D0 (da) 1987-11-03
ZA878245B (en) 1988-05-04
JPS63130589A (ja) 1988-06-02
DD275048A5 (de) 1990-01-10
PT86055B (pt) 1990-07-31
AU606087B2 (en) 1991-01-31
AU8065587A (en) 1988-05-05
IL84315A0 (en) 1988-03-31
FI874804L (fi) 1988-05-05
PT86055A (en) 1987-12-01
GB8626344D0 (en) 1986-12-03
NO874489D0 (no) 1987-10-28
US4814346A (en) 1989-03-21
FI874804A7 (fi) 1988-05-05
NO874489L (no) 1988-05-05
HUT48611A (en) 1989-06-28
FI874804A0 (fi) 1987-11-02
NZ222411A (en) 1990-09-26
KR880006224A (ko) 1988-07-22

Similar Documents

Publication Publication Date Title
DK575687D0 (da) Bicycliske forbindelser samt deres fremstilling og anvendelse
DK443287A (da) Substituerede benzoylphenlurinstoffer samt deres fremstilling og anvendelse
DK381287D0 (da) Polypeptider samt deres fremstilling og anvendelse
DK420785D0 (da) 13-halogen- eller 13-hydroxymilbemyciner samt deres fremstilling og anvendelse
DK29686D0 (da) 13beta-alkyl-milbemycinderivater samt deres fremstilling og anvendelse
DK35884A (da) Lactampeptider samt deres fremstilling og anvendelse
DK248285A (da) Polypeptider samt deres fremstilling og anvendelse
DK515386D0 (da) Benzoylurinstofsalte samt deres fremstilling og anvendelse
DK289287D0 (da) 1-phenylalkylimidazol-4- og/eller -5-carboxamider samt deres fremstiling og anvendelse
DK172486A (da) Heterocyclyl-penem-forbindelser samt deres fremstilling og anvendelse
DK393285D0 (da) Substituerede carbonylphenylsulfonylguanidiner samt deres fremstilling og anvendelse
DK189584D0 (da) (5alfa)-20-spirox-1-en-3-oner samt deres fremstilling og anvendelse
DK35984A (da) Lactampeptider samt deres fremstilling og anvendelse
DK77286A (da) 1-0-acylerede hexosederivater samt deres fremstilling og anvendelse
DK206686A (da) Acylaminomethyl-penem-forbindelser samt deres fremstilling og anvendelse
DK181485A (da) 3-substituerede thiopyroner samt deres fremstilling og anvendelse
DK513386D0 (da) Optisk aktive acyloxazetidinoner samt deres fremstilling og anvendelse
DK437986D0 (da) 1-amino-3-phenyl-propan-2-ol-derivater samt deres fremstilling og anvendelse
DK361185D0 (da) 2-aminoalkyl-2-penem-forbindelser samt deres fremstilling og anvendelse
DK432187A (da) Penemforbindelser samt deres fremstilling og anvendelse
DK117587D0 (da) 5-acyloxy-13beta-alkyl-milbemycin-derivater samt deres fremstilling og anvendelse
DK13588D0 (da) Heterocyclylalkyl-2-penem-forbindelser samt deres fremstilling og anvendelse
DK439188D0 (da) Sulfonerede chlorbenzidiner samt deres fremstilling og anvendelse
DK471185D0 (da) 4-acylresorcinolethere samt deres fremstilling og anvendelse
DK482385D0 (da) Fluorerede resorcinolethere samt deres fremstilling og anvendelse

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment